We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I remember that Fruits and yes, it's quite a thing to do, not just pinging an email
Correct Meelie, RNS can take weeks from point of writing to issuing officially - I think it was Jkman(?) that posted a very good CEO overviewof what goes into RNSs. It's not a quick email they bang up in the morning and issue the next day, or even the next week.
Spinnaker..... for the sake of the, relatively, short term investors it would've been great if he had released the HT in two parts. But I don't think his priority is to the short term investor. He has had very large investors with him since the beginning, who are happy waiting until the summer.... what's another few months, when they've been with him for 15 years of up and down.
I also remember listening to one interview when RM said that RNS's take a lot of time to put together... from reading the huge contents of past RNS's my feeling is that he will roll everything into the next RNS including the 90 day/long covid/Active 2 and anything else he can give news on. It would be nice if that was April, but am prepared for it to be May.
The science is good, the company is solid. I'm pretty relaxed about the short term SP..... but very excited about the next jump up!
Thanks to Tornadotony again.... your chart predictions are solid, and it's great having on this board. I have incidentally doubled my money on one of your share tips/timings in just a month.... so a big thank you for that!
If there’s only the day 90 data left to analyse then results out possibly next week or the week after next? I doubt analysing it would take that long.
Well done Mike.
How long did that answer take to get? It must be at least 6 weeks. At least it was very positive and specific re SNG001. Possibly the first time I have seen anything official emanating from the government mentioning the company name. Are you able to post the link please.
However, in comparison to vaccines where orders were placed before authorisation and well before conclusion of trials, it is clear that there are no plans to contract orders before authorisation for use be that emergency use or not.
I am just considering whether to add to my holding at current SP but my confidence in AIM companies and government shenanigans has taken a knock since the unbelievable NCYT news.
I still am unsure why Synairgen appear not to be releasing the initial results for the home trial which they could have had by now. Is it the case that once the 90 day review had been incorporated into the trial they would not un-blind any of the results until all the information was collected due to possibility of bias? My slight concern is that they have already analysed the initial findings up to 28 or 30 days but have decided not to to release these if inconclusive or non-significant in the hope that the longer term analysis would strengthen the case. If the former scenario is correct and they have not yet un-blinded any results then I would feel a bit happier.
Overall I am still confident with the company and product but agree with most posters that the UK home trial results will probably not be sufficient in themselves to gain authorisation in the UK. I would love to be proved wrong.
Good luck all.
Spinnaker
Has anyone got. Rishi’s mobile number or maybe we can invite Matt out for a drink?
https://twitter.com/AIMdective/status/1381856013280804865?s=20
Well done Mike, another excellent poster advertising the potential positives we look forward to, soon.
Good find Mike - and potentially positive news for ramping up manufacturing.
We are definitely on the radar - it’s just a shame Matt Han****’s neighbour isn’t on the Board of Synairgen or we’d have EUA and orders already. A bit more patience required before the blockbuster RNS.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of placing advance orders for inhaled interferon beta, which is being trialled as a treatment for covid-19 in Newcastle’s Royal Victoria Infirmary and other hospitals.
Answered on
12 April 2021
On 30 November, we announced a £20 million Medicines and Diagnostics Manufacturing Transformation Fund. This will offer capital grants to businesses, incentivising them to place internationally mobile high value manufacturing investment, such as the manufacturing interferon beta in the United Kingdom.
The Department has been working constructively with Synairgen to assist them in generating data in support of their inhaled interferon beta treatment, SNG001. We continue to monitor progress on SNG001 closely. However, purchasing of therapeutics will only be considered once there is sufficient evidence of safety and efficacy and the Medicines and Healthcare products Regulatory Agency has provided marketing authorisation.